Latest Financial Results

Q3 2019

Quarter Ended Sep 30, 2019

Email Sign Up

Sign me up for:

Stock Information

2018 BIO International Convention Presentation

2019 BIO International Convention Presentation

Download 2019 BIO International Convention Presentation

Leadership

Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information

Company

Seneca Biopharmaceuticals, Inc.
20271 Goldenrod Lane
Suite 2024
Germantown, MD 20876
T: 301-366-4960

Investor Relations

investor@senecabio.com

Transfer Agent

American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
T: 718-921-8200